Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Titeux

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|July 8, 2026
History and future of RNA medicinesAlain Hovnanian, Guillaume Mondon, Matthias Titeux
Dermatologic Clinics|May 8, 2010
Gene therapy for recessive dystrophic epidermolysis bullosaMatthias Titeux, Valérie Pendaries, Alain Hovnanian
The Journal of Investigative Dermatology|April 17, 2017
The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic BreakthroughsMatthias Titeux, Araksya Izmiryan, Alain Hovnanian
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Antisense-Mediated Splice Modulation to Reframe TranscriptsMatthias Titeux, Sandrina Turczynski, Nathalie Pironon, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2018
Correction to: Antisense-Mediated Splice Modulation to Reframe TranscriptsMatthias Titeux, Sandrina Turczynski, Nathalie Pironon, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Antisense-mediated exon skipping to reframe transcriptsSandrina Turczynski, Matthias Titeux, Nathalie Pironon, et al.
Expert Opinion on Emerging Drugs|October 23, 2020
Emerging drugs for the treatment of epidermolysis bullosaMatthias Titeux, Mathilde Bonnet des Claustres, Araksya Izmiryan, et al.
Human Mutation|November 22, 2007
A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosaMatthias Titeux, Valérie Pendaries, Laure Tonasso, et al.
The Journal of Investigative Dermatology|August 8, 2016
Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB ModelSandrina Turczynski, Matthias Titeux, Laure Tonasso, et al.
The Journal of Investigative Dermatology|March 21, 2016
Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral VectorJoanna Jacków, Matthias Titeux, Soizic Portier, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|July 8, 2026
History and future of RNA medicinesAlain Hovnanian, Guillaume Mondon, Matthias Titeux
Dermatologic Clinics|May 8, 2010
Gene therapy for recessive dystrophic epidermolysis bullosaMatthias Titeux, Valérie Pendaries, Alain Hovnanian
The Journal of Investigative Dermatology|April 17, 2017
The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic BreakthroughsMatthias Titeux, Araksya Izmiryan, Alain Hovnanian
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Antisense-Mediated Splice Modulation to Reframe TranscriptsMatthias Titeux, Sandrina Turczynski, Nathalie Pironon, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2018
Correction to: Antisense-Mediated Splice Modulation to Reframe TranscriptsMatthias Titeux, Sandrina Turczynski, Nathalie Pironon, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Antisense-mediated exon skipping to reframe transcriptsSandrina Turczynski, Matthias Titeux, Nathalie Pironon, et al.
Expert Opinion on Emerging Drugs|October 23, 2020
Emerging drugs for the treatment of epidermolysis bullosaMatthias Titeux, Mathilde Bonnet des Claustres, Araksya Izmiryan, et al.
Human Mutation|November 22, 2007
A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosaMatthias Titeux, Valérie Pendaries, Laure Tonasso, et al.
The Journal of Investigative Dermatology|August 8, 2016
Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB ModelSandrina Turczynski, Matthias Titeux, Laure Tonasso, et al.
The Journal of Investigative Dermatology|March 21, 2016
Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral VectorJoanna Jacków, Matthias Titeux, Soizic Portier, et al.
Pageof 4